Updated on 2024/10/03

Information

 

写真a

 
SHIBAHARA DAISUKE
 
Organization
Faculty of Medical Sciences Research Institute for Deseases of the Chest Assistant Professor
School of Medicine Department of Medicine(Joint Appointment)
Title
Assistant Professor
Profile
臨床:入院・外来診療 研究:肺癌基礎研究 教育:医学生への講義

Degree

  • Doctor of Philosophy in Medicine

Research Interests・Research Keywords

  • Research theme:Mechanisms of drug resistance in lung cancer Tumor immune microenvironment

    Keyword:Lung cancer, resistance, tumor immune microenvironment

    Research period: 2023.4 - 2024.4

Papers

  • TIP60 is required for tumorigenesis in non-small cell lung cancer Reviewed International journal

    Daisuke Shibahara, Naoki Akanuma, Ikei S. Kobayashi, Eunyoung Heo, Mariko Ando, Masanori Fujii, Feng Jiang, P. Nicholas Prin, Gilbert Pan, Kwok-Kin Wong, Daniel B. Costa, Deepak Bararia, Daniel G. Tenen, Hideo Watanabe, Susumu S. Kobayashi

    Cancer Science   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.15785

  • Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Invited Reviewed International journal

    Yukie Kashima, Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David Plotnick, Hibiki Udagawa, Hiroki Izumi, Yuji Shibata, Kosuke Tanaka, Masanori Fujii, Akihiro Ohashi, Masahide Seki, Koichi Goto, Katsuya Tsuchihara, Yutaka Suzuki, Susumu S. Kobayashi

    Cancer Research   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/0008-5472.CAN-20-2811

  • Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer Invited Reviewed International journal

    Daisuke Shibahara, Kentaro Tanaka, Eiji Iwama, Naoki Kubo, Keiichi Ota, Koichi Azuma, Taishi Harada, Jiro Fujita, Yoichi Nakanishi, Isamu Okamoto

    Journal of Thoracic Oncology   2018.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jtho.2018.03.012

  • Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer Reviewed International journal

    Shibahara D., Tanaka K., Togao O., Shiraishi Y., Yoneshima Y., Iwama E., Yoshitake T., Ishigami K., Okamoto I.

    Clinical Lung Cancer   25 ( 6 )   581 - 586.e3   2024.9   ISSN:15257304

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Clinical Lung Cancer  

    The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases. • [11C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis. • Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.

    DOI: 10.1016/j.cllc.2024.06.010

    Scopus

    PubMed

  • Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations Invited Reviewed International journal

    Yu Inutsuka, Eiji Iwama, Yoshimasa Shiraishi, Yasuto Yoneshima, Daisuke Shibahara, Kentaro Tanaka, Isamu Okamoto

    Respiratory Investigation   2024.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.resinv.2024.02.001

  • Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review Reviewed International journal

    Yamamoto, Y; Shibahara, D; Mori, T; Otsubo, K; Shiraishi, Y; Yoneshima, Y; Iwama, E; Tanaka, K; Oda, Y; Okamoto, I

    THORACIC CANCER   15 ( 13 )   1106 - 1111   2024.5   ISSN:1759-7706 eISSN:1759-7714

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Thoracic Cancer  

    Tracheomediastinal fistula is a rare but life-threatening complication of cancer. We report a case of tracheomediastinal fistula induced by concurrent chemoradiotherapy in limited stage small cell lung cancer. Despite the treatment response, the metastatic paratracheal lymph node increased gradually during concurrent chemoradiotherapy, resulting in the occurrence of tracheomediastinal fistula and mediastinitis. Without any surgical intervention, the patient achieved successful recovery from mediastinitis through antibiotic treatment, although the tracheomediastinal fistula remained open. In this report, we also review previous studies of tracheomediastinal and bronchomediastinal fistulas and summarize the clinical features.

    DOI: 10.1111/1759-7714.15270

    Web of Science

    Scopus

    PubMed

  • YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells Invited Reviewed International journal

    Maako Nakajima, Kentaro Tanaka, Yasuto Yoneshima, Sho Yamashita, Daisuke Shibahara, Eiji Iwama, Isamu Okamoto

    Biochemical and Biophysical Research Communications   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2023.09.067

  • Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer Invited Reviewed International journal

    Shinichi Kimura, Taishi Harada, Kayo Ijichi, Kentaro Tanaka, Renpeng Liu, Daisuke Shibahara, Yuko Kawano, Kohei Otsubo, Yasuto Yoneshima, Eiji Iwama, Yoichi Nakanishi, Isamu Okamoto

    Lung Cancer   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.lungcan.2018.04.005

  • CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment Invited Reviewed International journal

    Yuko Kawano, Eiji Iwama, Kenji Tsuchihashi, Daisuke Shibahara, Taishi Harada, Kentaro Tanaka, Osamu Nagano, Hideyuki Saya, Yoichi Nakanishi, Isamu Okamoto

    Lung Cancer   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.lungcan.2017.09.008

▼display all

Books

  • EGFR-Directed Therapy in Lung Cancer

    So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi and Balazs Halmos( Role: Joint author)

    Cambridge University Press  2023.1 

     More details

    Language:Japanese   Book type:Scholarly book

Presentations

  • EGFR遺伝子変異陽性肺癌におけるDrug tolerant persister細胞による耐性獲得のメカニズム

    柴原大典

    第92回日本呼吸器学会・日本結核 非結核性抗酸菌症学会 九州支部 春季学術講演会  2024.3 

     More details

    Event date: 2024.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

  • 非小細胞肺癌におけるTIP60の役割

    第64回日本肺癌学会学術集会  2023.11 

     More details

    Event date: 2024.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  • TIP60 is required for tumorigenesis in non-small cell lung cancer

    Daisuke Shibahara, Naoki Akanuma, Ikei S. Kobayashi, Eunyoung Heo, Mariko Ando, Masanori Fujii, Feng Jiang, P. Nicholas Prin, Gilbert Pan, Kwok-Kin Wong, Daniel B. Costa, Deepak Bararia, Daniel G. Tenen, Hideo Watanabe, and Susumu S. Kobayashi

    2023.9 

     More details

    Event date: 2024.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

Research Projects

  • EGFR遺伝子変異陽性肺癌におけるDrug tolerant persister細胞の新規遺伝子の同定

    2023.4

    九州大学大学院医学研究院 

      More details

    Authorship:Principal investigator 

    EGFR遺伝子変異陽性肺癌は、分子標的薬の治療に著効するが耐性獲得は必発であり、耐性獲得機序の解明及び新規治療薬の開発は急務である。分子標的薬による治療過程で癌細胞は様々な耐性を獲得するが、その前段階の状態としてDrug tolerant persister (DTP) 細胞という概念がある。治療開始して腫瘍は一旦縮小していくが、残存病変の中に細胞死を回避して生き残った細胞が存在する。この生き残った細胞をDTP細胞といい、DTP細胞が様々な耐性機序を獲得することで、最終的に臨床で問題となる腫瘍増大につながる。そこで本研究では、DTP細胞に発現する新規遺伝子を同定し、その機能を明らかにする。加えて、その遺伝子を阻害することによってより強力な治療効果を発揮し、ひいては耐性獲得の克服も目指す。

  • EGFR遺伝子変異陽性肺癌におけるDrug tolerant persister細胞の新規遺伝子の同定

    Grant number:23K19544  2023 - 2024

    日本学術振興会  科学研究費助成事業  研究活動スタート支援

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • 新日本先進医療研究財団助成

    2023

      More details

    Grant type:Donation

  • 2023年度 日本イーライリリーイノベーション研究助成

    2023

      More details

    Grant type:Donation

Class subject

  • 人工呼吸器管理

    2023.10 - 2024.3   Second semester

Travel Abroad

  • 2020.8 - 2023.3

    Staying countory name 1:United States   Staying institution name 1:Beth Israel Deaconess Medical Center/Harvard Medical School

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Internal Medicine / Respiratory Medicine

Clinician qualification

  • Specialist

    The Japanese Respiratory Society

  • Specialist

    Japanese Association for Acute Medicine(JAAM)

  • Specialist

    The Japanese Society of Internal Medicine(JSIM)

Year of medical license acquisition

  • 2007